Submissions from 2020
Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group), P. M. Meraj, K. Patel, A. Patel, R. Doshi, G. Srinivas, R. Jauhar, B. Kaplan, A. Sharma, Y. Cao, R. Sharma, and +2 additional authors
Submissions from 2019
Commentary in reply to: Gross et al, Radiation Oncologists' Role in End-of-Life Care: A Perspective From Medical Oncologists, B. Bloom, M. W. Saif, and L. Potters
Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - A randomized phase III study, F. Bludau, G. Welzel, T. Reis, Y. Abo-Madyan, E. Sperk, F. Schneider, S. Clausen, A. M. Ruder, M. M. Ghaly, F. A. Giordano, and +2 additional authors
Gastric Neuroendocrine Tumor and Duodenal Gastrinoma with Chronic Autoimmune Atrophic Gastritis, W. C. Chen, R. R. P. Warner, N. Harpaz, H. Zhu, S. Roayaie, and M. K. Kim
Major complications from radiotherapy following treatment for atypical meningiomas, T. Dawley, Z. Rana, H. Abou-Al-Shaar, A. Goenka, and M. Schulder
The current state of randomized clinical trial evidence for prostate brachytherapy, R. T. Dess, P. D. Soni, W. C. Jackson, A. Berlin, B. W. Cox, S. Jolly, J. A. Efstathiou, F. Y. Feng, A. U. Kishan, D. E. Spratt, and +2 additional authors
Merging Orthovoltage X-Ray Minibeams spare the proximal tissues while producing a solid beam at the target, F. A. Dilmanian, S. Krishnan, W. E. McLaughlin, B. Lukaniec, J. T. Baker, S. Ailawadi, K. N. Hirsch, R. F. Cattell, R. Roy, J. G. Eley, and +14 additional authors
Tumor control and survival in patients with ten or more brain metastases treated with stereotactic radiosurgery: a retrospective analysis, M. I. Ehrlich, E. Schiff, J. P. Knisely, J. Chang, X. Qian, A. Goenka, and M. Schulder
Why Smart Oncology Clinicians do Dumb Things: A Review of Cognitive Bias in Radiation Oncology, S. B. Evans, D. Cain, A. Kapur, D. Brown, and T. Pawlicki
Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer, E. Gogineni, I. Zhang, Z. Rana, M. Marrero, G. Gill, A. Sharma, A. C. Riegel, S. Teckie, and M. Ghaly
Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas., J. Ivanidze, M. Roytman, E. Lin, R. S. Magge, D. J. Pisapia, B. Liechty, N. Karakatsanis, R. Ramakrishna, J. Knisely, S. C. Pannullo, and +2 additional authors
Spine Radiosurgery Dosimetry—A Simple Way Forward, J. P. Knisely
Historical Aspects of Stereotactic Radiosurgery: Concepts, People, and Devices, J. P. Knisely and M. L. J. Apuzzo
Letter to the Editor: How safe, really, is jugular paraganglioma radiosurgery?, J. P. Knisely, R. Ramakrishna, and T. H. Schwartz
Local Radiation Therapy for Palliation in Patients With Multiple Myeloma of the Spine, D. Mark, P. Gilbo, R. Meshrekey, and M. Ghaly
Radiation recall pneumonitis in the setting of immunotherapy and radiation: A focused review, K. McGovern, M. Ghaly, M. Esposito, K. Barnaby, and N. Seetharamu
Evidence for the Role of Mindfulness in Cancer: Benefits and Techniques., R. Mehta, K. Sharma, L. Potters, A. G. Wernicke, and B. Parashar
Worldwide Access to Stereotactic Radiosurgery, S. C. Pannullo, D. A. Julie, S. Chidambaram, O. D. Balogun, S. C. Formenti, M. L. J. Apuzzo, and J. P. S. Knisely
Tumor detection using computational fiberscope system, X. Qian
Dosimetric impact of placement errors in optically stimulated luminescent in vivo dosimetry in radiotherapy, M. Tariq, C. Gomez, and A. C. Riegel
Survival impact of treatment-related time intervals in nasopharyngeal carcinoma in the United States, T. Tham, S. Ahn, S. Teckie, A. Roche, D. Frank, D. Kraus, and P. Costantino
Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience, M. Wotman, M. Ghaly, L. Massaro, T. Tham, N. Seetharamu, D. Kamdar, D. Frank, D. Kraus, and S. Teckie
Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio, J. B. Yu, T. F. Beck, M. S. Anscher, A. M. Baschnagel, K. K. Brock, D. J. Carlson, M. M. Dominello, R. J. Kimple, J. P. Knisely, J. C. Keen, and +4 additional authors
The ASTRO Research Portfolio: Where Do We Go From Here?, J. B. Yu, T. F. Beck, M. S. Anscher, A. M. Baschnagel, K. K. Brock, D. J. Carlson, M. M. Dominello, R. J. Kimple, J. P. S. Knisely, J. C. Keen, and +4 additional authors
Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer, M. J. Zelefsky, M. Kollmeier, S. McBride, M. Varghese, B. Mychalczak, R. Gewanter, M. K. Garg, L. Happersett, D. A. Goldman, B. W. Cox, and +3 additional authors
A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer., H. Zhang, Y. Cao, J. Antone, A. C. Riegel, M. Ghaly, L. Potters, and A. Jamshidi
Submissions from 2018
Consider Using Virtual Bolus, J. Chang and J. Baker
Restricted single isocenter for multiple targets dynamic conformal arc (RSIMT DCA) technique for brain stereotactic radiosurgery (SRS) planning., J. Chang, A. G. Wernicke, and S. C. Pano
PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival, Z. Ding, H. Dhruv, A. Kwiatkowska-Piwowarczyk, R. Ruggieri, J. Kloss, M. Symons, P. Pirrotte, J. M. Eschbacher, N. L. Tran, and J. C. Loftus
Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety, G. Ezzell, B. Chera, A. Dicker, E. Ford, L. Potters, L. Santanam, and S. Weintraub
Implementation and utilization of hypofractionation for breast cancer, P. Gilbo, L. Potters, and L. Lee
Prophylactic Cranial Irradiation for Resectable Small-Cell Lung Cancer, A. Halthore, A. Goenka, R. Sharma, and J. P. S. Knisely
Massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, A. N. Halthore, A. Levy, T. Philip, and S. Teckie
2D–3D registration for cranial radiation therapy using a 3D kV CBCT and a single limited field-of-view 2D kV radiograph, R. Munbodh, J. P. S. Knisely, D. A. Jaffray, and D. J. Moseley
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539, L. Rogers, P. Zhang, M. A. Vogelbaum, A. Perry, L. S. Ashby, J. M. Modi, A. M. Alleman, J. Galvin, J. P. S. Knisely, M. P. Mehta, and +5 additional authors
Reducing seed waste and increasing value of dynamic intraoperative implantation of Pd-103 seeds in prostate brachytherapy, P. K. Taylor and A, C. Riegel
Hypofractionated stereotactic radiosurgery: a new treatment strategy for giant cavernous sinus hemangiomas, X. Wang, H. Zhu, J. Knisely, G. Mei, X. Liu, J. Dai, Y. Mao, L. Pan, Z. Qin, and E. Wang
Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer, I. Zhang, P. Gilbo, N. Kohn, and B. Cox
Submissions from 2017
The world's first single-room proton therapy facility: Two-year experience, J. Contreras, T. Zhao, S. Perkins, B. Sun, S. Goddu, S. Mutic, B. Bottani, S. Endicott, E. Klein, J. Bradley, and +6 additional authors
Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors, M. De Witt, A. Gamble, D. Hanson, D. Markowitz, C. Powell, S. Al Dimassi, M. Atlas, J. Boockvar, R. Ruggieri, and M. Symons
Stereotactic radiosurgery of the brain: A review of common indications, P. Gilbo, I. Zhang, and J. Knisely
Patient-reported Quality of Life After Proton Beam Therapy for Prostate Cancer: The Effect of Prostate Size, A. Goenka, N. B. Newman, H. Fontanilla, O. Cahlon, B. Chon, H. Tsai, E. Hug, C. Brown, C. Vargas, and R. R. Parikh
Improving efficiency and safety in external beam radiation therapy treatment delivery using a Kaizen approach, A. Kapur, N. Adair, M. O'Brien, N. Naparstek, T. Cangelosi, P. Zuvic, S. Joseph, J. Meier, B. Bloom, and L. Potters
A Detailed Dosimetric Analysis of Spinal Cord Tolerance in High-Dose Spine Radiosurgery., E. Katsoulakis, A. Jackson, B. Cox, M. Lovelock, and Y. Yamada
The Ever-Evolving Role of the Academic Clinical Physicist, E. E. Klein, J. Fontenot, and N. Dogan
Novel Wavelet-Based Segmentation of Prostate CBCT Images with Implanted Calypso Transponders., Y. Liu, Z. Saleh, Y. Song, M. Chan, X. Li, C. Shi, X. Qian, and X. Tang
Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism, D. Markowitz, G. Ha, R. Ruggieri, and M. Symons
Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment, L. L. Puckett, E. Luitweiler, L. Potters, and S. Teckie
In vivo dosimetry with optically stimulated luminescent dosimeters for conformal and intensity-modulated radiation therapy: A 2-year multicenter cohort study, A. C. Riegel, Y. Chen, A. Kapur, L. Apicello, A. Kuruvilla, A. J. Rea, A. Jamshidi, and L. Potters
Breast Density Awareness and Knowledge, and Intentions for Breast Cancer Screening in a Diverse Sample of Women Age Eligible for Mammography, M. Santiago-Rivas, S. Benjamin, J. Z. Andrews, and L. Jandorf
Colony Stimulating Factor-1 Receptor Inhibitors-A 4 for 1 Deal in the Desire to Improve Glioma Radiotherapy, B. Skeie, R. Ruggieri, J. A. Boockvar, and M. Symons
The more IGRT systems, the merrier?, B. Sun, J. Chang, and Y. Rong
NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease, A. M. Szema, E. Forsyth, B. Ying, S. A. Hamidi, J. J. Chen, S. Hwang, J. C. Li, D. S. Dwyer, J. M. Ramiro-Diaz, L. V. Gonzalez Bosc, and +1 additional author
Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma, S. Teckie, S. Qi, M. Chelius, S. Lovie, M. Hsu, A. Noy, C. Portlock, and J. Yahalom
Defining the value of magnetic resonance imaging in prostate brachytherapy using time-driven activity-based costing, N. G. Thaker, P. F. Orio, and L. Potters
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: setting a new standard., B. A. Vellayappan, L. M. Halasz, J. P. S. Knisely, E. L. Chang, and S. S. Lo
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial, L. I. Wagner, S. L. Pugh, W. Small, J. Kirshner, K. Sidhu, M. J. Bury, A. S. DeNittis, T. E. Alpert, B. F. Bloom, D. W. Bruner, and +6 additional authors
Counterpoint: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer: The Data for Adjuvant Radiotherapy Remain Strong., W. J. Wu and L. Potters
Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery., I. Zhang, J. Antone, J. Li, S. Saha, A. C. Riegel, L. Vijeh, J. Lauritano, M. Marrero, S. Salas, M. Schulder, H. Zinkin, A. Goenka, and J. Knisely
Use Only as Directed, I. Zhang and J. P. S. Knisely
Accuracy evaluation of a six-degree-of-freedom couch using cone beam CT and IsoCal phantom with an in-house algorithm, Q. Zhang, J. Driewer, S. Wang, S. Li, Y. Cao, A. Jamshidi, B. W. Cox, J. P. S. Knisely, L. Potters, E. E. Klein, and +3 additional authors
Still equivalent for dose calculation in the Monte Carlo era? A comparison of free breathing and average intensity projection CT datasets for lung SBRT using three generations of dose calculation algorithms, K. Zvolanek, R. Ma, C. Zhou, X. Liang, S. Wang, V. Verma, X. Zhu, Q. Zhang, J. Driewer, D. Zheng, and +4 additional authors
Submissions from 2016
Introduction to Big Data in Radiation Oncology: Exploring Opportunities for Research, Quality Assessment, and Clinical Care., S. H. Benedict, I. El Naqa, and E. E. Klein
Neuro-oncology biotech industry progress report, S. Chakraborty, I. Bodhinayake, A. Chiluwal, D. J. Langer, R. Ruggieri, M. Symons, and J. A. Boockvar
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial, H. Chen, X. Liu, C. B. Brendler, D. P. Ankerst, R. J. Leach, P. J. Goodman, M. S. Lucia, C. M. Tangen, L. Wang, J. Xu, and +8 additional authors
A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases - An initial report., R. J. Colaco, J. B. Yu, J. S. Bond, R. S. Bindra, J. N. Contessa, J. P. S. Knisely, and V. L. Chiang
Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation, G. Daniels, X. Zhang, X. Zhong, L. Santiago, L. H. Wang, X. Wu, J. Y. Zhang, F. Liang, X. Li, P. Lee, and +6 additional authors
Radioresistance of Brain Tumors, K. Kelley, J. Knisely, M. Symons, and R. Ruggieri
It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence., C C Kirwan, C E Coles, J Bliss, C. Kirwan, L. Kilburn, L. Fox, M. Cheang, C. Griffin, R. Sharma, M. Mukesh, and +16 additional authors
Reply To: One Week of Radiotherapy for Glioblastoma: A Noninferiority Trial?, J. Knisely
Stereotactic radiosurgery/stereotactic body radiation therapy— reflection on the last decade’s achievements and future directions, J. Knisely, A. Sahgal, S. Lo, L. Ma, and E. Chang
To the editor: Radiation plus Chemotherapy in Low-Grade Glioma, J. Knisely and M. Schulder
PCI in resected small-cell lung cancer, J. Knisely, R. Sharma, A. Goenka, and A. Halthore
Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme, A. J. Kole, H. S. Park, D. N. Yeboa, C. E. Rutter, C. D. Corso, S. Aneja, N. H. Lester-Coll, B. R. Mancini, J. P. Knisely, and J. B. Yu
Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes, M. Kushnirsky, V. Nguyen, J. S. Katz, J. Steinklein, L. Rosen, C. Warshall, M. Schulder, and J. P. Knisely
Stereotactic radiosurgery alone for limited brain metastases: are we ready for prime time?, S. S. Lo, K. J. Redmond, E. L. Chang, M. Foote, J. P. Knisely, and A. Sahgal
Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma, D. Markowitz, C. Powell, N. L. Tran, M. E. Berens, T. C. Ryken, L. Rosen, S. Sun, M. Symons, Y. Al-Abed, R. Ruggieri, and +2 additional authors
Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma, S. Mukherjee, J. Baidoo, A. Fried, D. Atwi, S. Dolai, J. Boockvar, M. Symons, R. Ruggieri, K. Raja, and P. Banerjee
Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities, R. R. Parikh, R. Rhome, E. Hug, H. Tsai, O. Cahlon, B. Chon, and A. Goenka
Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells, S. Ponnurangam, P. R. Dandawate, A. Dhar, O. W. Tawfik, R. R. Parab, P. D. Mishra, P. Ranadive, R. Sharma, G. Mahajan, D. Subramaniam, and +7 additional authors
A Systems Approach Using Big Data to Improve Safety and Quality in Radiation Oncology, L. Potters, E. Ford, S. Evans, T. Pawlicki, and S. Mutic
A Novel Method of Assessing Cardiac Toxicity: Deformable Registration to Quantitatively Assess Dose Received by Cardiac Structures, L. Puckett, M. Weinreich, A. C. Riegel, S. Saba, S. Henry, S. Rosen, E. E. Klein, X. Qian, J. Z. Andrews, J. P. Knisely, and +1 additional author
Outcomes in Patients with Vestibular Schwannoma after Subtotal Resection and Adjuvant Radiosurgery, H. Radwan, M. Bruce Eisenberg, J. P. S. Knisely, M. M. Ghaly, and M. Schulder
The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer, C. Rey, B. Faustin, I. Mahouche, R. Ruggieri, C. Brulard, F. Ichas, I. Soubeyran, L. Lartigue, and F. De Giorgi
Deformable image registration and interobserver variation in contour propagation for radiation therapy planning., A. C. Riegel, J. G. Antone, H. Zhang, P. Jain, J. Raince, A. Rea, A. M. Bergamo, A. Kapur, and L. Potters
Impact of surgery for stage IA non-smallcell lung cancer on patient quality of life, R. M. Schwartz, R. Yip, I. Olkin, D. Sikavi, E. Taioli, S. Andaz, R. Shah, J. Lowry, M. Lim, J. O'Brien, and +89 additional authors
Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics., B. F. Taylor, J. P. Knisely, J. M. Qian, J. B. Yu, and V. L. Chiang
High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck, S. Teckie, B. H. Lok, S. Rao, S. I. Gutiontov, Y. Yamada, S. L. Berry, M. J. Zelefsky, and N. Y. Lee
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing, N. G. Thaker, T. J. Pugh, U. Mahmood, S. Choi, T. E. Spinks, N. E. Martin, T. T. Sio, B. W. Cox, L. Potters, S. J. Frank, and +8 additional authors
Tumor-Treating Fields-A Fundamental Change in Locoregional Management for Glioblastoma, I. Zhang and J. P. S. Knisely
Tumor treating fields-effective, but at what cost?, I. Zhang and J. P. S. Knisely
Setup uncertainties in linear accelerator based stereotactic radiosurgery and a derivation of the corresponding setup margin for treatment planning, M. Zhang, Q. Zhang, H. Gan, S. Li, and S. M. Zhou
Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs. pencil beam target dose differences for lung stereotactic body radiotherapy, D. Zheng, Q. Zhang, X. Liang, X. Zhu, V. Verma, S. Wang, and S. Zhou
Target dose conversion modeling from pencil beam (PB) to Monte Carlo (MC) for lung SBRT, D. Zheng, X. Zhu, Q. Zhang, X. Liang, W. Zhen, C. Lin, V. Verma, S. Wang, A. Wahl, C. Zhang, and +2 additional authors
High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA(2)-IIE and sPLA(2)-V Expression in Macrophages, S. Zhu, Y. Wang, W. Chen, W. Li, A. Wang, J. Li, H. Yang, K. J. Tracey, J. D'Angelo, H. Wang, and +2 additional authors
Submissions from 2015
Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study, M. J. Abrams, K. E. Huber, J. P. Knisely, B. W. Chang, S. M. Russo, and M. W. Saif
Extra-CNS metastasis from glioblastoma: a rare clinical entity, M. Awan, S. Liu, A. Sahgal, S. Das, S. T. Chao, E. L. Chang, J. P. S. Knisely, K. Redmond, J. W. Sohn, S. S. Lo, and +4 additional authors
Celecoxib inhibits Ewing sarcoma cell migration via actin modulation, C. A. Behr, A. J. Hesketh, M. Barlow, R. D. Glick, M. Symons, B. M. Steinberg, and S. Z. Soffer